Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163888 | SCV000214479 | likely benign | Hereditary cancer-predisposing syndrome | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000457384 | SCV000556482 | benign | Tuberous sclerosis 2 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001657912 | SCV001875026 | likely benign | not provided | 2021-09-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000457384 | SCV002041266 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163888 | SCV002534108 | likely benign | Hereditary cancer-predisposing syndrome | 2022-01-25 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002505201 | SCV002809139 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2022-02-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001657912 | SCV002822233 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | TSC2: BP4 |